Symbols / AIFF Stock $1.75 +2.34% Firefly Neuroscience, Inc.

Technology • Software - Application • United States • NCM
AIFF (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Technology
Industry Software - Application
CEO Mr. Greg Lipschitz
Exch · Country NCM · United States
Market Cap 27.25M
Enterprise Value 24.12M
Income -17.93M
Sales 1.58M
FCF (ttm) -9.79M
Book/sh 0.57
Cash/sh 0.20
Employees 17
Insider 10d —
IPO Apr 06, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 17.20
P/B 3.08
P/C —
EV/EBITDA -2.88
EV/Sales 15.23
Quick Ratio 1.35
Current Ratio 1.82
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.36
EPS next Y —
EPS Growth —
Revenue Growth 10.28%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -45.65%
ROE -131.44%
ROIC —
Gross Margin 51.96%
Oper. Margin -4.14%
Profit Margin 0.00%
Shs Outstand 15.57M
Shs Float 13.58M
Insider Own 28.00%
Instit Own 7.88%
Short Float 8.14%
Short Ratio 0.78
Short Interest 1.02M
52W High 3.77
vs 52W High -53.58%
52W Low 0.62
vs 52W Low 182.26%
Beta —
Impl. Vol. —
Rel Volume 0.02
Avg Volume 10.38M
Volume 167.14K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.71
Price $1.75
Change 2.34%
About

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.75
Latest analyst target
3. DCF / Fair value
$-11.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.75
Low
—
High
—
Mean
—
News
RSS: Latest AIFF news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-10 DECAPRIO DAVID President — 44,872 $0.00 $0
2026-03-10 LIPSCHITZ GREGORY Chief Executive Officer — 65,988 $0.00 $0
2025-10-22 WINDSOR PRIVATE CAPITAL LIMITED PARTNERSHIP Beneficial Owner of more than 10% of a Class of Security — 130,753 $2.07 $290,185
2025-10-17 WINDSOR PRIVATE CAPITAL LIMITED PARTNERSHIP Beneficial Owner of more than 10% of a Class of Security — 102,675 $2.55 $269,154
2025-10-14 WINDSOR PRIVATE CAPITAL LIMITED PARTNERSHIP Beneficial Owner of more than 10% of a Class of Security — 166,572 $2.65 $456,677
2024-10-22 JOHNSON DAVID IAN Officer and Director — 557,885 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.14
+957.41%
0.11
-78.31%
0.50
0.00
Operating Revenue
1.11
+926.85%
0.11
-77.41%
0.48
0.00
Cost Of Revenue
0.50
0.00
—
0.00
Reconciled Cost Of Revenue
0.50
0.00
—
0.00
Gross Profit
0.65
+497.22%
0.11
-78.31%
0.50
0.00
Operating Expense
9.25
-0.41%
9.29
+159.73%
3.58
+9.96%
3.25
Research And Development
1.48
-24.16%
1.95
+163.70%
0.74
-41.75%
1.27
Selling General And Administration
7.77
+5.92%
7.33
+158.69%
2.83
+43.18%
1.98
Selling And Marketing Expense
0.80
-33.39%
1.20
+87.95%
0.64
+883.08%
0.07
General And Administrative Expense
6.97
+13.61%
6.13
+179.28%
2.20
+14.67%
1.92
Salaries And Wages
—
—
—
0.76
Other Gand A
6.97
+13.61%
6.13
+179.28%
2.20
+138.70%
0.92
Total Expenses
9.75
+4.94%
9.29
+159.73%
3.58
+9.96%
3.25
Operating Income
-8.61
+6.26%
-9.18
-198.25%
-3.08
+5.35%
-3.25
Total Operating Income As Reported
-8.86
+11.92%
-10.05
-226.64%
-3.08
+7.54%
-3.33
EBITDA
-19.55
-89.36%
-10.32
-299.46%
-2.58
+19.28%
-3.20
Normalized EBITDA
-8.57
+7.90%
-9.30
-254.94%
-2.62
+18.88%
-3.23
Reconciled Depreciation
0.17
+156.72%
0.07
0.00
-100.00%
0.01
EBIT
-19.72
-89.80%
-10.39
-302.05%
-2.58
+19.63%
-3.21
Total Unusual Items
-10.98
-977.33%
-1.02
-2854.05%
0.04
+23.33%
0.03
Total Unusual Items Excluding Goodwill
-10.98
-977.33%
-1.02
-2854.05%
0.04
+23.33%
0.03
Special Income Charges
-1.60
-83.52%
-0.87
0.00
-100.00%
0.03
Other Special Charges
1.35
—
—
0.06
Impairment Of Capital Assets
0.25
-71.28%
0.87
0.00
-100.00%
0.08
Write Off
—
—
—
-0.00
Net Income
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Pretax Income
-19.88
-90.07%
-10.46
-301.92%
-2.60
+31.33%
-3.79
Net Non Operating Interest Income Expense
-0.07
-1.45%
-0.07
-283.33%
-0.02
+96.86%
-0.57
Interest Expense Non Operating
0.16
+130.43%
0.07
+283.33%
0.02
-96.86%
0.57
Net Interest Income
-0.07
-1.45%
-0.07
-283.33%
-0.02
+96.86%
-0.57
Interest Expense
0.16
+130.43%
0.07
+283.33%
0.02
-96.86%
0.57
Interest Income Non Operating
0.09
0.00
—
—
Interest Income
0.09
0.00
—
—
Other Income Expense
-11.20
-826.55%
-1.21
-344.74%
0.49
+1235.14%
0.04
Other Non Operating Income Expenses
-0.22
-17.89%
-0.19
-141.58%
0.46
+6428.57%
0.01
Gain On Sale Of Security
-9.37
-6364.83%
-0.14
-491.89%
0.04
—
Tax Provision
0.01
+150.00%
0.00
+100.00%
0.00
0.00
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.01
0.00
Net Income Including Noncontrolling Interests
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Net Income From Continuing Operation Net Minority Interest
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Net Income From Continuing And Discontinued Operation
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Net Income Continuous Operations
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Normalized Income
-8.90
+5.69%
-9.44
-258.67%
-2.63
+31.08%
-3.82
Net Income Common Stockholders
-24.53
-134.52%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Otherunder Preferred Stock Dividend
4.65
0.00
—
—
Diluted EPS
—
-1.60
-219.30%
-0.50
+31.30%
-0.73
Basic EPS
—
-1.60
-219.30%
-0.50
+31.30%
-0.73
Basic Average Shares
—
6.55
+26.03%
5.19
+0.00%
5.19
Diluted Average Shares
—
6.55
+26.03%
5.19
+0.00%
5.19
Diluted NI Availto Com Stockholders
-24.53
-134.52%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Depreciation Amortization Depletion Income Statement
—
—
—
0.00
Depreciation And Amortization In Income Statement
—
—
—
0.00
Gain On Sale Of PPE
—
—
—
0.17
Rent And Landing Fees
—
—
—
0.23
Rent Expense Supplemental
—
—
—
0.23
Line Item Trend 2025-12-31
Total Assets
10.48
Current Assets
4.03
Cash Cash Equivalents And Short Term Investments
2.75
Cash And Cash Equivalents
2.75
Cash Financial
—
Receivables
0.19
Accounts Receivable
0.19
Gross Accounts Receivable
0.20
Allowance For Doubtful Accounts Receivable
-0.01
Other Receivables
—
Inventory
0.11
Raw Materials
0.11
Work In Process
0.00
Finished Goods
0.00
Prepaid Assets
0.98
Total Non Current Assets
6.45
Net PPE
0.15
Gross PPE
0.30
Accumulated Depreciation
-0.16
Machinery Furniture Equipment
0.03
Other Properties
0.27
Goodwill And Other Intangible Assets
6.04
Goodwill
5.17
Other Intangible Assets
0.86
Non Current Prepaid Assets
0.27
Total Liabilities Net Minority Interest
2.84
Current Liabilities
2.82
Payables And Accrued Expenses
2.11
Payables
1.35
Accounts Payable
1.35
Current Accrued Expenses
0.77
Current Debt And Capital Lease Obligation
—
Current Debt
—
Other Current Borrowings
—
Current Deferred Liabilities
0.23
Current Deferred Revenue
0.23
Other Current Liabilities
0.48
Total Non Current Liabilities Net Minority Interest
0.02
Non Current Deferred Liabilities
0.02
Non Current Deferred Revenue
0.02
Stockholders Equity
7.64
Common Stock Equity
7.64
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
14.02
Ordinary Shares Number
13.96
Treasury Shares Number
0.06
Additional Paid In Capital
119.25
Retained Earnings
-111.61
Total Equity Gross Minority Interest
7.64
Total Capitalization
7.64
Working Capital
1.21
Invested Capital
7.64
Total Debt
—
Net Debt
—
Net Tangible Assets
1.60
Tangible Book Value
1.60
Dueto Related Parties Current
—
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.19
-33.13%
-6.16
-183.38%
-2.17
+24.90%
-2.89
Cash Flow From Continuing Operating Activities
-8.19
-33.13%
-6.16
-183.38%
-2.17
+24.90%
-2.89
Net Income From Continuing Operations
-19.88
-90.08%
-10.46
-301.84%
-2.60
+31.30%
-3.79
Depreciation Amortization Depletion
0.17
+156.72%
0.07
0.00
-100.00%
0.01
Depreciation
0.17
+156.72%
0.07
0.00
-100.00%
0.01
Depreciation And Amortization
0.17
+156.72%
0.07
0.00
-100.00%
0.01
Other Non Cash Items
0.94
+2147.62%
0.04
—
0.46
Stock Based Compensation
0.78
-71.30%
2.72
+822.37%
0.29
+391.67%
0.06
Asset Impairment Charge
0.25
-71.28%
0.87
—
—
Operating Gains Losses
10.72
+6773.08%
0.16
—
-0.03
Gain Loss On Investment Securities
9.37
+5905.77%
0.16
—
—
Gain Loss On Sale Of PPE
—
—
—
-0.09
Change In Working Capital
-1.18
-365.62%
0.45
+227.21%
0.14
-65.22%
0.39
Change In Receivables
-0.03
+24.32%
-0.04
+43.08%
-0.07
-340.74%
0.03
Changes In Account Receivables
-0.03
+24.32%
-0.04
+43.08%
-0.07
—
Change In Inventory
-0.04
0.00
—
—
Change In Prepaid Assets
0.51
+797.26%
-0.07
-343.33%
0.03
+150.00%
0.01
Change In Payables And Accrued Expense
-1.58
-391.88%
0.54
-49.81%
1.08
+1202.04%
-0.10
Change In Accrued Expense
-0.95
-179.18%
-0.34
-132.57%
1.05
+5916.67%
-0.02
Change In Payable
-0.63
-171.35%
0.88
+2575.76%
0.03
+141.25%
-0.08
Change In Account Payable
-0.63
-171.35%
0.88
+2422.86%
0.04
+143.75%
-0.08
Change In Other Working Capital
-0.04
-438.46%
0.01
+101.43%
-0.91
-302.00%
0.45
Investing Cash Flow
-2.49
-421.59%
-0.48
-23.58%
-0.39
-247.33%
0.26
Cash Flow From Continuing Investing Activities
-2.49
-421.59%
-0.48
-23.58%
-0.39
-247.33%
0.26
Net PPE Purchase And Sale
-0.13
+13.51%
-0.15
0.00
-100.00%
0.26
Purchase Of PPE
-0.13
+13.51%
-0.15
0.00
—
Sale Of PPE
—
—
—
0.26
Capital Expenditure
-0.13
+69.16%
-0.41
-7.51%
-0.39
—
Net Investment Purchase And Sale
—
—
—
0.00
Sale Of Investment
—
—
—
0.00
Net Business Purchase And Sale
-2.36
0.00
—
—
Purchase Of Business
-2.36
0.00
—
—
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.27
+30.83%
-0.39
—
Net Other Investing Changes
—
-0.06
—
—
Financing Cash Flow
11.62
+84.46%
6.30
+35.67%
4.64
+128.16%
2.04
Cash Flow From Continuing Financing Activities
11.62
+84.46%
6.30
+35.67%
4.64
+128.16%
2.04
Net Issuance Payments Of Debt
2.53
+29.46%
1.96
0.00
-100.00%
1.75
Issuance Of Debt
2.53
+29.46%
1.96
0.00
-100.00%
1.75
Short Term Debt Issuance
2.53
+29.46%
1.96
0.00
-100.00%
1.75
Net Short Term Debt Issuance
2.53
+29.46%
1.96
0.00
-100.00%
1.75
Net Common Stock Issuance
0.00
-100.00%
4.31
-7.22%
4.64
+1501.03%
0.29
Proceeds From Stock Option Exercised
9.09
+25144.44%
0.04
0.00
—
Changes In Cash
0.94
+381.38%
-0.33
-115.97%
2.08
+450.42%
-0.59
Beginning Cash Position
1.81
-15.54%
2.14
+3594.83%
0.06
-91.12%
0.65
End Cash Position
2.75
+51.77%
1.81
-15.54%
2.14
+3594.83%
0.06
Free Cash Flow
-8.32
-26.67%
-6.57
-156.84%
-2.56
+11.55%
-2.89
Interest Paid Supplemental Data
0.00
-100.00%
0.01
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
0.00
-100.00%
4.31
-7.22%
4.64
+1501.03%
0.29
Issuance Of Capital Stock
0.00
-100.00%
4.31
-7.22%
4.64
+1501.03%
0.29
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category